- Researchers in Bristol found that 14 days after one dose of the Pfizer vaccine, it was 80% effective at preventing people over 80 years of age from developing symptomatic illness severe enough to be admitted to hospital.
- After nearly two months of COVID-19 vaccinations, researchers have released various studies that prove the efficacy of the vaccines in real-world conditions: The drugs all prevented severe illness, hospitalizations, and deaths.
- More than 20 million people in the UK have received at least one vaccine dose as of last week.
- Vaccination will stop people passing on coronavirus “almost completely”, the Public Health England head of immunization forecasts.
- COVID-19 case rates and hospitalizations decreased across all UK regions and age groups last week.
US & Canada
- The United States is now administering an average of 2 million vaccine doses per day.
- Biden says there will be enough vaccine available for all adults by the end of May, as Johnson & Johnson makes a deal with Merck & Co to boost supply.
- Canada’s vaccine panel now recommends four months between vaccine doses, matching the UK policy. This new COVID-19 vaccination protocol will allow health officials to inoculate more people, sooner.
- On March 2, Nigeria successfully received its first vaccines and will now commence its inoculation program, becoming the third country in Africa to get the shots through COVAX.
- The Indian maker Covaxin says its vaccine is safe and effective, with an interim efficacy of 81% in Phase 3 clinical trials.
- As part of efforts to boost India's immunization drive, the Central Government has permitted a round-the-clock Covid-19 vaccination programme. Now, hospitals are free to administer vaccinations 24/7.